India has been a hub for vaccine productions and Indian pharmaceutical companies have contributed immensely to the vaccine related projects running all over the world. Indian companies have also been pioneers in starting working on COVID-19 vaccine and finishing preclinical trials. Recently, two ...
A yellow fever vaccination certificate is required from travelers aged 9 months and over arriving within 6 days of departure from an area with a risk of yellow fever transmission. Keep updated with India's COVID-19 requirements, such as quarantine, testing, or vaccine certificates, through your...
Travel Health COVID Vaccineand theCOVID Pandemic Immunity Fruits and vegetables..nature’s multivitamins Probiotic food:Why you need it in your diet Ultimate Nutrition tips to fight Flu and Improve immunity Truth about Prebiotic :What no one told you ...
COVAXIN��, India's first indigenous COVID vaccine is developed by the corona vaccine manufacturer Bharat Biotech. It is an inactivated COVID-19 vaccine and human trials are about to commence across India.
CoWin, India’s digital platform for COVID-19 vaccination, is allowing travelers to download an international version of their COVID-19 vaccine certificate, which is compliant with WHO’s international travel guidelines. This feature went live on September 30, 2021, and allows fully vaccinated indi...
ZyCoV-D is a three-dose vaccine which will be administered first on day zero, the 28th and then on the 56th day. With this approval, India now has its first Covid-19 vaccine for the adolescents in the 12-18 age group, besides the adult population, the company said in a statement. ...
Pfizer said on Monday it was in discussions with the Indian government seeking an "expedited approval pathway" for its vaccine. MORE: Places the U.S. Government Warns Not to Travel Right Now "Unfortunately, our vaccine is not registered in India although our application was submit...
Since May 1, anyone aged 18 or over is eligible for a Covid vaccine although this expansion of the vaccination program has been hampered given the shortages of doses that have been reported throughout the country by national media.
According to the ministry, about 96 percent of the population who are 15 and above have received at least one COVID-19 vaccine dose while about 83 percent of this group have received two doses.■
Adjusting for test-negative certificate before departure, the quality control of which was partly ques- tionable, the cumulative incidence can potentially be up to 2.3–2.6 times greater than abovementioned estimates. Abbreviations COVID-19 novel coronavirus disease 2019 ARS-CoV-2 Severe Acute ...